3 companies
D'Ieteren Group
Market Cap: €8.6b
Operates as an investment company in Belgium, France, rest of Europe, and internationally.
DIE
€164.10
7D
-4.5%
1Y
-9.5%
UCB
Market Cap: €49.4b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€259.50
7D
6.3%
1Y
59.5%
argenx
Market Cap: €45.3b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€728.80
7D
1.4%
1Y
42.7%